JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.5
Cite Score
SJR: 0.129 / SNIP: 0.140
Volume 17, Issue 2 (2025)
Iran J War Public Health 2025, 17(2): 175-182 |
Back to browse issues page
Article Type:
Subject:
Ethics code: IR.BMSU.BAQ.REC.1403.086
History
Received: 2025/05/12 | Accepted: 2025/06/29 | Published: 2025/07/3
Received: 2025/05/12 | Accepted: 2025/06/29 | Published: 2025/07/3
How to cite this article
Jabbari S, Arabfard M, Ghazvini A, Vahedi E, Shahriary A, Ghanei M. Integrated Framework for Evaluating Chronic Lung Injury Severity in Chemical Exposure Victims. Iran J War Public Health 2025; 17 (2) :175-182
URL: http://ijwph.ir/article-1-1595-en.html
URL: http://ijwph.ir/article-1-1595-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abstract (299 Views)
Aims: Lung injuries caused by exposure to chemical agents, such as mustard gas, represent one of the most significant long-term complications in chemical veterans. These injuries differ from chronic obstructive pulmonary disease in etiology and require specific diagnostic and therapeutic methods. This study aimed to provide a framework for the diagnosis and assessment of the severity of chronic lung injuries in chemical casualties to assist physicians in clinical decision-making and improve patient management.
Materials & Methods: This applied and evidence-based study was conducted on 15 males who suffered from chronic lung injury due to chemical agents. The framework used included the Chronic Obstructive Pulmonary Disease Assessment Test, Clinical Chronic Obstructive Pulmonary Disease Questionnaire, and Chronic Respiratory Disease Questionnaire, as well as the pulmonary function test. To classify the severity of chronic lung injury, the majority voting algorithm was employed.
Findings: There was a strong correlation between the questionnaire scores and the pulmonary function test results. A strong positive correlation (r=0.95) was observed between the Chronic Obstructive Pulmonary Disease Assessment Test results and the physician’s clinical opinion, while a strong negative correlation (r=-0.93) was noted between Chronic Obstructive Pulmonary Disease Assessment Test scores and the forced expiratory volume in one second ratio. Additionally, there was a strong positive correlation (r=0.72) between the Clinical Chronic Obstructive Pulmonary Disease Questionnaire results and the physician’s opinion, and a strong inverse correlation (r=-0.86) between Clinical Chronic Obstructive Pulmonary Disease Questionnaire scores and forced expiratory volume in one second.
Conclusion: The used framework is an effective tool for the rapid and accurate assessment of the severity of chronic lung injury in chemical casualties.
Materials & Methods: This applied and evidence-based study was conducted on 15 males who suffered from chronic lung injury due to chemical agents. The framework used included the Chronic Obstructive Pulmonary Disease Assessment Test, Clinical Chronic Obstructive Pulmonary Disease Questionnaire, and Chronic Respiratory Disease Questionnaire, as well as the pulmonary function test. To classify the severity of chronic lung injury, the majority voting algorithm was employed.
Findings: There was a strong correlation between the questionnaire scores and the pulmonary function test results. A strong positive correlation (r=0.95) was observed between the Chronic Obstructive Pulmonary Disease Assessment Test results and the physician’s clinical opinion, while a strong negative correlation (r=-0.93) was noted between Chronic Obstructive Pulmonary Disease Assessment Test scores and the forced expiratory volume in one second ratio. Additionally, there was a strong positive correlation (r=0.72) between the Clinical Chronic Obstructive Pulmonary Disease Questionnaire results and the physician’s opinion, and a strong inverse correlation (r=-0.86) between Clinical Chronic Obstructive Pulmonary Disease Questionnaire scores and forced expiratory volume in one second.
Conclusion: The used framework is an effective tool for the rapid and accurate assessment of the severity of chronic lung injury in chemical casualties.
Keywords:
References
1. Wattana M, Bey T. Mustard gas or sulfur mustard: An old chemical agent as a new terrorist threat. Prehosp Disaster Med. 2009;24(1):19-29. [Link] [DOI:10.1017/S1049023X0000649X]
2. Turini S. Biological activity of the products of interaction of mustard gas with human skin tissues. Middle East J Appl Sci Technol. 2024;7(1):13-103. [Link] [DOI:10.46431/MEJAST.2024.7103]
3. Dubey S, Yu Z, Stephens EM, Lazrak A, Ahmad I, Aggarwal S, et al. Oxidative injury to lung mitochondrial DNA is a key contributor to the development of chemical lung injury. BioRxiv 624949 [Preprint]. 2024 [cited 2024, November, 25]. Available from: https://www.biorxiv.org/content/10.1101/2024.11.22.624949v1. [Link] [DOI:10.1101/2024.11.22.624949]
4. Muhammad BA, Hama SA, Hawrami KAM, Karim SH, Ahmed GS, Rahim HM. Long-term health complications of chemical weapon exposure: A study on Halabja chemical attack survivors (Iraqi Kurds). Inhal Toxicol. 2024;36(1):26-30. [Link] [DOI:10.1080/08958378.2024.2301985]
5. Beheshti J, Mark EJ, Akbaei HM, Aslani J, Ghanei M. Mustard lung secrets: Long term clinicopathological study following mustard gas exposure. Pathol Res Pract. 2006;202(10):739-44. [Link] [DOI:10.1016/j.prp.2006.04.008]
6. Ghanei M, Akhlaghpoor S, Moahammad MM, Aslani J. Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol. 2004;16(13):845-9. [Link] [DOI:10.1080/08958370490506682]
7. Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol. 2005;19(3):297-315. [Link] [DOI:10.1111/j.1472-8206.2005.00325.x]
8. Balali‐Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 2006;99(4):273-82. [Link] [DOI:10.1111/j.1742-7843.2006.pto_429.x]
9. Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: Analysis of 197 cases. Chest. 1997;112(3):734-8. [Link] [DOI:10.1378/chest.112.3.734]
10. Zafarghandi MR, Soroush MR, Mahmoodi M, Naieni KH, Ardalan A, Dolatyari A, et al. Incidence of cancer in Iranian sulfur mustard exposed veterans: A long-term follow-up cohort study. Cancer Causes Control. 2013;24(1):99-105. [Link] [DOI:10.1007/s10552-012-0094-8]
11. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54. [Link] [DOI:10.1183/09031936.00102509]
12. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35. [Link] [DOI:10.1183/09031936.00177210]
13. Van Der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13. [Link] [DOI:10.1186/1477-7525-1-13]
14. Zhou Z, Zhou A, Zhao Y, Chen P. Evaluating the clinical COPD uestionnaire: A systematic review. Respirology. 2017;22(2):251-62. [Link] [DOI:10.1111/resp.12970]
15. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-8. [Link] [DOI:10.1136/thx.42.10.773]
16. Martin LL. Validity and reliability of a quality-of-life instrument: The chronic respiratory disease questionnaire. Clin Nurs Res. 1994;3(2):146-56. [Link] [DOI:10.1177/105477389400300207]
17. Larson J, Covey M, Berry J, Wirtz S, Kim M, editors. Reliability and validity of the chronic respiratory disease questionnaire. New York: American Review of Respiratory Disease; 1993. [Link]
18. Wijkstra PJ, TenVergert EM, Van Altena R, Otten V, Postma DS, Kraan J, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994;49(5):465-7. [Link] [DOI:10.1136/thx.49.5.465]
19. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997;52(10):879-87. [Link] [DOI:10.1136/thx.52.10.879]
20. Güell R, Casan P, Sangenís M, Sentís J, Morante F, Borras J, et al. Spanish translation and validation of a quality-of-life questionnaire for patients with chronic obstructive pulmonary disease. ARCHIVOS DE BRONCONEUMOLOGÍA. 1995;31(5):202-10. [Spanish] [Link] [DOI:10.1016/S0300-2896(15)30925-X]
21. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52(3):187-92. [Link] [DOI:10.1016/S0895-4356(98)00157-7]
22. Guyatt GH, Townsend M, Keller JL, Singer J. Should study subjects see their previous responses: Data from a randomized control trial. J Clin Epidemiol. 1989;42(9):913-20. [Link] [DOI:10.1016/0895-4356(89)90105-4]
23. Lacasse Y, Wong E, Guyatt G. A systematic overview of the measurement properties of the Chronic Respiratory Questionnaire. Can Respir J. 1997;4(3):131-9. [Link] [DOI:10.1155/1997/717139]
24. Moran LA, Guyatt GH, Norman GR. Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument. J Clin Epidemiol. 2001;54(6):571-9. [Link] [DOI:10.1016/S0895-4356(00)00342-5]
25. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55. [Link] [DOI:10.1164/rccm.200703-456SO]
26. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-65. [Link] [DOI:10.1164/rccm.201204-0596PP]
27. Tsiligianni IG, Van Der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12:20. [Link] [DOI:10.1186/1471-2466-12-20]
28. Miravitlles M, García-Sidro P, Fernández-Nistal A, Buendía MJ, Espinosa De Los Monteros MJ, Molina J. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11:147. [Link] [DOI:10.1186/1477-7525-11-147]
29. Sundh J, Ställberg B, Lisspers K, Kämpe M, Janson C, Montgomery S. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a clinical population. COPD. 2016;13(1):57-65. [Link] [DOI:10.3109/15412555.2015.1043426]
30. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12-5. [Link] [DOI:10.3109/15412555.2011.630248]
31. Zhou Z, Zhou A, Zhao Y, Duan J, Chen P. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: A cross-sectional analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1675-82. [Link] [DOI:10.2147/COPD.S161225]
32. Daga MK, Mawari G, Singh S, Walad S, Khubiyal S, Bharali D, et al. Correlation of CAT, CCQ, and mMRC scores in patients with COPD with exacerbation and after treatment. J Clin Diagn Res. 2020;14(9). [Link] [DOI:10.7860/JCDR/2020/44301.13927]
33. Tan M, Jian W, Liang Q, Li S, Cui H. Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease. J South Med Univ. 2021;41(7):1119-24. [Chinese] [Link]
34. Canavan JL, Dilaver D, Clark AL, Jones SE, Nolan CM, Kon SS, et al. Clinical COPD questionnaire in patients with chronic respiratory disease. Respirology. 2014;19(7):1006-12. [Link] [DOI:10.1111/resp.12350]
35. Ghobadi H, Ahari SS, Kameli A, Lari SM. The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients. TANAFFOS. 2012;11(2):22-6. [Link]
36. Badr NM, Elrefaey BH, El-Hadidy HA, Moussa HA. Correlation of forced expiratory volume in one second and COPD Assessment Test Scores in chronic obstructive pulmonary disease patients. J Adv Pharm Educ Res. 2019;9(1):49-52. [Link]
37. Khyalappa R, Thanekar S. Use of CAT score & it's correlation with spirometry in stable COPD patients. J Adv Med Dent Sci Res. 2019;7(1):72-5. [Link]
38. Miravitlles M, Koblizek V, Esquinas C, Milenkovic B, Barczyk A, Tkacova R, et al. Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in Central and Eastern Europe: The POPE study. Respir Med. 2019;150:141-8. [Link] [DOI:10.1016/j.rmed.2019.03.007]
39. Carvalho-Jr LCS, Trimer R, Arêas GP, Caruso FC, Zangrando KT, Jürgensen SP, et al. COPD assessment test and FEV1: Do they predict oxygen uptake in COPD?. Int J COPD. 2018;2018:3149-56. [Link] [DOI:10.2147/COPD.S167369]
40. Varol Y, Ozacar R, Balci G, Usta L, Taymaz Z. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate COPD severity and exacerbation rates. COPD. 2014;11(2):221-5. [Link] [DOI:10.3109/15412555.2013.836169]
41. Al Moamary MS, Tamim HM. The reliability of an Arabic version of the self-administered standardized chronic respiratory disease questionnaire (CRQ-SAS). BMC Pulm Med. 2011;11:21. [Link] [DOI:10.1186/1471-2466-11-21]
42. Oga T, Nishimura K, Tsukino M, Hajiro T, Sato S, Ikeda A, et al. Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease. Qual Life Res. 2004;13(6):1109-16. [Link] [DOI:10.1023/B:QURE.0000031345.56580.6a]
43. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, et al. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(6):1874-8. [Link] [DOI:10.1164/ajrccm.159.6.9807097]
44. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(4):1185-9. [Link] [DOI:10.1164/ajrccm.158.4.9802091]
45. Gaude GS, Lolly M, Hattiholi J, Patil B. Reliability and validity of clinical COPD questionnaire and chronic respiratory questionnaire in patients with COPD using tiotropium over a period of 26 weeks. Indian J Chest Dis Allied Sci. 2020;62:197-201. [Link] [DOI:10.5005/ijcdas-62-4-197]
46. Guyatt G, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: Conclusions from a randomized control trial. Respir Med. 1989;83(4):293-7. [Link] [DOI:10.1016/S0954-6111(89)80199-4]